M. Stubbs

发表

Deep vein thrombosis

M. Mouyis, Maria Thomas, M. Stubbs, 2018, British Medical Journal.

Adrenal haemorrhage and infarction in the setting of vaccine-induced immune thrombocytopenia and thrombosis after SARS-CoV-2 (Oxford–AstraZeneca) vaccination

U. Srirangalingam, T. Chung, E. Armeni, 2022, Endocrinology, Diabetes & Metabolism Case Reports.

Whole genome sequencing of a sporadic primary immunodeficiency cohort

William J. Astle, Sri V. V. Deevi, Kenneth G. C. Smith, 2018, Nature.

A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.

Ania, Eleanor, Dewhurst, 2018 .

Real-World Evidence of Caplacizumab Use in the Management of Acute TTP.

S. Lane, R. Gooding, J. Hanley, 2020, Blood.

RAS mutation status and bortezomib therapy for relapsed multiple myeloma

J. Downward, Dean Smith, Madhu S. Kumar, 2015, British journal of haematology.

Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia

D. Werring, H. Jäger, N. Losseff, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures

Henning Gall, Fengyuan Hu, Kevin Rue-Albrecht, 2018, American journal of human genetics.

Genetic Identification of Two Novel Loci Associated with Steroid-Sensitive Nephrotic Syndrome.

A. Adeyemo, J. Wetzels, D. Gale, 2019, Journal of the American Society of Nephrology : JASN.

Identification of a homozygous recessive variant in PTGS1 resulting in a congenital aspirin-like defect in platelet function

W. Ouwehand, K. Downes, J. Stephens, 2020, Haematologica.

Whole-genome sequencing of a sporadic primary immunodeficiency cohort

William J. Astle, Sri V. V. Deevi, Kenneth G. C. Smith, 2020, Nature.

Germline mutations in the transcription factor IKZF5 cause thrombocytopenia.

Randy J Read, Karyn Megy, Suthesh Sivapalaratnam, 2019, Blood.

Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpura

M. Hubank, D. Gale, L. Galicier, 2021, Haematologica.

The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura

M. Scully, J. Westwood, W. Thomas, 2022, British journal of haematology.

Administration of immunoglobulin G‐degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti‐ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission

M. Scully, M. Thomas, C. Kjellman, 2018, British Journal of Haematology.

Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune‐mediated thrombotic thrombocytopenic purpura

M. Scully, J. Westwood, M. Thomas, 2019, British journal of haematology.

Delayed normalisation of ADAMTS13 activity in acute Thrombotic Thrombocytopenic Purpura in the caplacizumab era.

M. Scully, J. Westwood, M. Thomas, 2023, Blood.

Long-term risk of relapse in immune-mediated Thrombotic Thrombocytopenic Purpura and the role of anti-CD20 therapy.

M. Scully, J. Westwood, C. Bagot, 2022, Blood.

Recombinant ADAMTS13 in Severe Neonatal Thrombotic Thrombocytopenic Purpura.

G. Kendall, M. Scully, M. Stubbs, 2022, The New England journal of medicine.